Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: -0.26% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 17 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $29K 100.0% | — | — | — |
| Cost of Revenue | $14K 48.5% | — | — | — |
| Gross Profit | $15K 51.5% | — | — | — |
| Research & Development | $656K 2227.1% | $833K | $1.5M | $930K |
| Selling, General & Admin | $3.2M 11018.4% | $1.8M | $1.7M | $1.3M |
| Total Operating Expenses | $4.1M 14074.6% | $3.4M | $4.9M | $4.3M |
| Operating Income | -$4.1M -14023.1% | -$3.4M | -$4.9M | -$4.3M |
| Interest Expense | — | $96K | $22K | — |
| Other Income (Expense), net | $40K 137.3% | $11K | -$10K | $34K |
| Pretax Income | -$4.1M -13885.8% | -$3.4M | -$4.9M | -$4.3M |
| Net Income | -$4.1M -13885.8% | -$3.4M | -$4.9M | -$4.3M |
| Per Share | ||||
| EPS (Basic) | $-0.44 | $-0.54 | $-1.09 | $-0.95 |
| EPS (Diluted) | $-0.44 | $-0.54 | $-1.09 | $-0.95 |
| Weighted Avg Shares (Basic) | 8.9M | 6.1M | 4.5M | 4.5M |
| Weighted Avg Shares (Diluted) | 8.9M | 6.1M | 4.5M | 4.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company has neither positive free cash flow nor a collected share count, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
1/5 of the 9 checks — 4 couldn't be scored (see above), so the score is out of the 5 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$4M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 4 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: -841%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 4 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2025 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-05
No standout strengths flagged.
Nothing notable to watch.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Cost of Revenue | — | — | — | 48.5 |
| Gross Profit | — | — | — | 51.5 |
| R&D | — | — | — | 2227.1 |
| SG&A | — | — | — | 11018.4 |
| Operating Income | — | — | — | -14023.1 |
| Net Income | — | — | — | -13885.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on RMSGW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.